Abstract

MARTINEZ-CORDERO, Humberto et al. Consensus of the Latin American Study Group on Multiple Myeloma (MM) GELAMM for the management of MM in a state of Pandemic SARS-CoV-2 / COVID-19. rev.colomb.cancerol. [online]. 2020, vol.24, suppl.1, pp.227-240.  Epub May 10, 2021. ISSN 0123-9015.  https://doi.org/10.35509/01239015.656.

COVID-19 disease was detected in late 2019 in Wuhan, China. Due to its rapid spread, it was initially declared a health emergency, but after cases with indigenous transmission were identified outside China, characterized by considerably high mortality in countries such as Italy and Spain, it was declared a pandemic by the World Health Organization. It has been shown that elderly patients with a history of chronic diseases, including cancer, develop a severe disease, presenting a higher risk of mortality from SARS-CoV2 / COVID-19. This becomes especially important in the management of patients with Multiple Myeloma (MM), generating new challenges, opportunities for improvement and learning opportunities in the health professionals, which will contribute to the risk-benefit analysis of immunosuppressive treatment for this type of pathology.

The consensus aims to provide guidance for the management of patients with MM in these times when the health professional requires information to deliver efficient therapies in patient care.

Keywords : COVID-19; multiple myeloma; treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )